Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: a sociotechnical analysis
- PMID: 17368860
- DOI: 10.1016/j.healthpol.2007.02.007
Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: a sociotechnical analysis
Abstract
Objective: To obtain more insight into the process of potential implementation of a screening program, which aims to identify carriers of cystic fibrosis and haemoglobinopathies before pregnancy, in order to enable couples at high risk of having a child with these disorders, to make informed reproductive decisions.
Methods: Use of sociotechnical analysis, based on a model of co-evolution between technology and society, and, for comparison, the study of the implementation processes of two already existing health care programs with similar aspects to the screening program at issue.
Results: Factors important for success appeared to be the existence of sociotechnical niches, in which technological options can be developed and studied in an experimental setting; a structural approach of providing information to future parents; a party that can articulate demand; governmental involvement in the attunement between various stakeholders; and a screening infrastructure in which large-scale DNA diagnostic services are available.
Conclusions: Successful implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies will depend on changes at both regime and landscape level, including the establishment of a new preconceptional health care setting and a clearly visible public health authority which can coordinate, monitor and evaluate such an initiative in public health care.
Similar articles
-
Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: a focus group study.Public Health. 2003 Nov;117(6):396-403. doi: 10.1016/S0033-3506(03)00136-7. Public Health. 2003. PMID: 14522154
-
[Preconceptional carrier screening should not be delayed].Ned Tijdschr Geneeskd. 2011;155:A3205. Ned Tijdschr Geneeskd. 2011. PMID: 21504638 Dutch.
-
Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services.Community Genet. 2003;6(1):5-13. doi: 10.1159/000069540. Community Genet. 2003. PMID: 12748433
-
Update on population-based preconception and prenatal cystic fibrosis carrier screening.J Okla State Med Assoc. 2003 Oct;96(10):482-4. J Okla State Med Assoc. 2003. PMID: 14619603 Review.
-
Genetic screening in reproductive health care.Clin Obstet Gynecol. 2008 Mar;51(1):3-23. doi: 10.1097/GRF.0b013e318160f241. Clin Obstet Gynecol. 2008. PMID: 18303496 Review.
Cited by
-
Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia.Healthcare (Basel). 2018 Aug 31;6(3):108. doi: 10.3390/healthcare6030108. Healthcare (Basel). 2018. PMID: 30200297 Free PMC article.
-
Ethical, legal, and social issues in health technology assessment for prenatal/preconceptional and newborn screening: a workshop report.Public Health Genomics. 2009;12(1):4-10. doi: 10.1159/000153430. Epub 2008 Sep 3. Public Health Genomics. 2009. PMID: 19023190 Free PMC article.
-
A case study of haemoglobinopathy screening in the Netherlands: witnessing the past, lessons for the future.Ethn Health. 2012;17(3):217-39. doi: 10.1080/13557858.2011.604126. Epub 2011 Aug 8. Ethn Health. 2012. PMID: 21819310 Free PMC article.
-
Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers.BMC Public Health. 2009 Sep 15;9:338. doi: 10.1186/1471-2458-9-338. BMC Public Health. 2009. PMID: 19754950 Free PMC article.
-
Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective.Front Pediatr. 2021 Oct 6;9:706394. doi: 10.3389/fped.2021.706394. eCollection 2021. Front Pediatr. 2021. PMID: 34692604 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical